Stokes Family Office’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $436K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $657K | Buy |
|
|||||
|
2023
Q2 | $503K | Buy |
|
|||||
|
2023
Q1 | $360K | Sell |
|
|||||
|
2022
Q4 | $468K | Buy |
|
|||||
|
2022
Q3 | $297K | Sell |
|
|||||
|
2022
Q2 | $436K | Buy |
|
|||||
|
2022
Q1 | $336K | Buy |
|
|||||
|
2021
Q4 | $215K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $300K | Buy |
|
|||||
|
2021
Q1 | $267K | Buy |
|
|||||
|
2020
Q4 | $244K | Buy |
|
|||||
|
2020
Q3 | $207K | Buy |
|